StacyStratemannKillenMD

Summary

• Dr. Stacy Killen is a pediatric cardiologist based in Nashville, TN, and the co-director of Fetal Cardiology for Vanderbilt University Medical Center. She completed her medical education at the University of Texas Southwestern Medical School, followed by a residency and chief residency in Pediatrics at the University of Texas Southwestern Medical School and a fellowship in Pediatric Cardiology, with additional training in Advanced Cardiac Imaging, at Vanderbilt University Medical Center. Dr. Killen has contributed to multiple publications, including research on prenatal surveillance and fetal heart conditions, with several works cited by other scholarly publications. Additionally, she plays a significant role in clinical trials, serving as the Site Primary Investigator for the STOP BLOQ clinical trial for mothers with anti-Ro/SSA antibodies whose pregnancies at risk for fetal heart block, as the Site Primary Investigator for the FAST trial for management of fetal tachycardia, and as a Site Investigator for the CORD-CHD study.
  
  Dr. Killen's clinical and research efforts seek to improve the care of mothers and fetuses whose pregnancies are complicated by fetal congenital heart disease and arrhythmias. She has authored articles and book chapters on fetal supraventricular tachycardia, fetal long QT syndrome, fetal immune-mediated carditis, prenatal diagnosis of congenital heart disease, and management of special populations with hypoplastic left heart syndrome.
  
  Dr. Killen is also the co-chair of the Pediatric Heart Institute Nutrition Program and helped develop a multi-interventional nutrition program for newborns with congenital heart disease. Additionally, she serves on the education and the program leaders committees for the Fetal Heart Society, on the Critical Congenital Heart Disease Screening Workgroup for the State of Tennessee, and on the Genetics Advisory Committee for the State of Tennessee.